It is a matter of debate if the sequencing of SHH-activated medulloblastomas can be restricted to tumors which show p53 accumulation (> 5% of nuclei), and/or signs of cytological anaplasia or if all SHH-activated medulloblastoma should be sequenced. This evidence concerns the gene SHH and medulloblastoma.